HACOR Score to Predict NIV Failure in Patients with COVID-related Hypoxemic Respiratory Failure Managed in the Ordinary Ward and in the Critical Care Setting

Overview

Journal Intern Emerg Med

Publisher Springer

Specialties Emergency Medicine
General Medicine

Date 2024 May 13

PMID 38739206

Authors

Francesco Pepe

Ginevra Fabiani

Carolina Cogozzo

Valerio Mazzilli

Maurizio Villanti

Riccardo Pini

Francesca Innocenti

Affiliations

Soon will be listed here.

Abstract

We evaluated the prevalence of non-invasive ventilation (NIV) failure among patients with COVID-19-related pneumonia, managed in the ordinary ward and in the HDU/ICU and we tested the prognostic role of the HACOR score in those different settings. This is a retrospective study, conducted in the University-Hospital Careggi. We included all subjects with COVID-19 and ARF requiring NIV between March 2020 and May 2021, respectively managed in the ordinary ward (G1) and in the critical care setting (G2). Clinical parameters, HACOR and SOFA score were evaluated at Day 0 and after 1, 2 and 5 days of treatment. The primary outcome was NIV failure. 13% G1 patients and 40% G2 patients underwent endotracheal intubation (ETI). NIV was successful in 60% G1 AND 43% G2 patients (p < 0.001). In G1, compared to those with successful NIV, patients who underwent ETI, had a higher HACOR since the baseline evaluation (T0: 6 [5-6] vs 5 [3-6]; T1: 6 [5-6] vs 5 [3-6], all p < 0.05). An HACOR score > 5 was associated with an increased prevalence of ETI independent to an advanced age and a SOFA score > 5 both in G1 (T1: RR 4.87, 95% CI 1.462-16.275; T5: 3.630, 95% CI 0.979-13.462) and G2 (T0: 1.76, 95% CI 0.906-3.422; T1: 3.38, 95% CI 1.386-8.265). Among patients with COVID-related-ARF, NIV could be managed in the ordinary ward in a consistent proportion of patients and, among them, an HACOR score > 5 was independently associated with increased NIV failure from the earliest evaluations.

References

Tortola D, Magnani E, Giorgini E, Zani M, Pazzaglini C, Sambo P . Managing Complexity: The Experience of an Italian Internal Medicine Unit During the SARS-CoV-2 Pandemic, Looking to the Future. SN Compr Clin Med. 2022; 4(1):233. PMC: 9610320. DOI: 10.1007/s42399-022-01320-z. View

Duca A, Memaj I, Zanardi F, Preti C, Alesi A, Della Bella L . Severity of respiratory failure and outcome of patients needing a ventilatory support in the Emergency Department during Italian novel coronavirus SARS-CoV2 outbreak: Preliminary data on the role of Helmet CPAP and Non-Invasive Positive Pressure.... EClinicalMedicine. 2020; 24:100419. PMC: 7301102. DOI: 10.1016/j.eclinm.2020.100419. View

Rochwerg B, Brochard L, Elliott M, Hess D, Hill N, Nava S . Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J. 2017; 50(2). DOI: 10.1183/13993003.02426-2016. View

Grasselli G, Calfee C, Camporota L, Poole D, Amato M, Antonelli M . ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies. Intensive Care Med. 2023; 49(7):727-759. PMC: 10354163. DOI: 10.1007/s00134-023-07050-7. View

Brusasco C, Corradi F, Di Domenico A, Raggi F, Timossi G, Santori G . Continuous positive airway pressure in COVID-19 patients with moderate-to-severe respiratory failure. Eur Respir J. 2020; 57(2). PMC: 7545055. DOI: 10.1183/13993003.02524-2020. View

Grieco D, Menga L, Raggi V, Bongiovanni F, Anzellotti G, Tanzarella E . Physiological Comparison of High-Flow Nasal Cannula and Helmet Noninvasive Ventilation in Acute Hypoxemic Respiratory Failure. Am J Respir Crit Care Med. 2019; 201(3):303-312. DOI: 10.1164/rccm.201904-0841OC. View

Aliberti S, Sotgiu G, Martinez Garcia M . Blood eosinophils do not predict inhaled budesonide response in bronchiectasis. Eur Respir J. 2020; 56(3). DOI: 10.1183/13993003.02210-2020. View

Calligaro G, Lalla U, Audley G, Gina P, Miller M, Mendelson M . The utility of high-flow nasal oxygen for severe COVID-19 pneumonia in a resource-constrained setting: A multi-centre prospective observational study. EClinicalMedicine. 2020; 28:100570. PMC: 7536126. DOI: 10.1016/j.eclinm.2020.100570. View

Zucman N, Mullaert J, Roux D, Roca O, Ricard J . Prediction of outcome of nasal high flow use during COVID-19-related acute hypoxemic respiratory failure. Intensive Care Med. 2020; 46(10):1924-1926. PMC: 7362315. DOI: 10.1007/s00134-020-06177-1. View

10.

Innocenti F, Lazzari C, Paolucci E, De Paris A, Lagomarsini A, Guerra F . Role of prognostic scores in predicting in-hospital mortality and failure of non-invasive ventilation in adults with COVID-19. Intern Emerg Med. 2022; 17(8):2367-2377. PMC: 9345392. DOI: 10.1007/s11739-022-03058-x. View

11.

Rodriguez M, Arrive F, Thille A, Frat J . [High-flow nasal oxygen in acute hypoxemic respiratory failure]. Rev Mal Respir. 2022; 39(7):607-617. DOI: 10.1016/j.rmr.2022.06.001. View

12.

Duan J, Han X, Bai L, Zhou L, Huang S . Assessment of heart rate, acidosis, consciousness, oxygenation, and respiratory rate to predict noninvasive ventilation failure in hypoxemic patients. Intensive Care Med. 2016; 43(2):192-199. DOI: 10.1007/s00134-016-4601-3. View

13.

Innocenti F, Tozzi C, Donnini C, de Villa E, Conti A, Zanobetti M . SOFA score in septic patients: incremental prognostic value over age, comorbidities, and parameters of sepsis severity. Intern Emerg Med. 2017; 13(3):405-412. DOI: 10.1007/s11739-017-1629-5. View

14.

Fiorino S, Bacchi-Reggiani L, Detotto E, Battilana M, Borghi E, Denitto C . Efficacy of non-invasive mechanical ventilation in the general ward in patients with chronic obstructive pulmonary disease admitted for hypercapnic acute respiratory failure and pH < 7.35: a feasibility pilot study. Intern Med J. 2015; 45(5):527-37. DOI: 10.1111/imj.12726. View

15.

Sainaghi P, Colombo D, Re A, Bellan M, Sola D, Balbo P . Natural history and risk stratification of patients undergoing non-invasive ventilation in a non-ICU setting for severe COPD exacerbations. Intern Emerg Med. 2016; 11(7):969-75. DOI: 10.1007/s11739-016-1473-z. View

16.

Beloncle F . Is COVID-19 different from other causes of acute respiratory distress syndrome?. J Intensive Med. 2023; . PMC: 10085872. DOI: 10.1016/j.jointm.2023.02.003. View

17.

Gattinoni L, Chiumello D, Rossi S . COVID-19 pneumonia: ARDS or not?. Crit Care. 2020; 24(1):154. PMC: 7160817. DOI: 10.1186/s13054-020-02880-z. View

18.

Perkins G, Ji C, Connolly B, Couper K, Lall R, Baillie J . Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19: The RECOVERY-RS Randomized Clinical Trial. JAMA. 2022; 327(6):546-558. PMC: 8787685. DOI: 10.1001/jama.2022.0028. View

19.

Guia M, Boleo-Tome J, Imitazione P, Polistina G, Alves C, Ishikawa O . Usefulness of the HACOR score in predicting success of CPAP in COVID-19-related hypoxemia. Respir Med. 2021; 187:106550. PMC: 8313899. DOI: 10.1016/j.rmed.2021.106550. View

20.

Innocenti F, Giordano L, Gualtieri S, Gandini A, Taurino L, Nesa M . Prediction of Mortality With the Use of Noninvasive Ventilation for Acute Respiratory Failure. Respir Care. 2020; 65(12):1847-1856. DOI: 10.4187/respcare.07464. View